AI assistant
Sending…
JOHNSON & JOHNSON — Director's Dealing 2015
Jun 8, 2015
29750_dirs_2015-06-08_662aa4e9-741b-454f-989a-66038312cb84.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEVRO CORP (NVRO)
CIK: 0001444380
Period of Report: 2015-06-08
Reporting Person: JOHNSON & JOHNSON (10% Owner)
Reporting Person: Johnson & Johnson Innovation - JJDC, Inc. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-06-08 | Common Stock | S | 1010265 | $47.94 | Disposed | 2066740 | Indirect |
Footnotes
F1: Represents the public offering price of $51.00 per share, less the underwriter's discount of $3.06 per share.
F2: The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person (formerly known as Johnson & Johnson Development Corporation).
More from JOHNSON & JOHNSON
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 13
Major Shareholding Notification
2026
May 1
Regulatory Filings
2026
Apr 27
Interim / Quarterly Report
2026
Apr 22
Regulatory Filings
2026
Apr 14
Major Shareholding Notification
2026
Apr 13
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 18
Regulatory Filings
2026
Mar 18